Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University ...

Costs for MS, Parkinson's and Alzheimer's Meds Keep Rising By Ernie Mundell HealthDay Reporter THURSDAY, Oct. 31, 2024 (HealthDay News) -- A person battling multiple sclerosis spent an average of ...

Generics can help lower costs, but the savings don't always make their way to patients THURSDAY, Oct. 31, 2024 (HealthDay News) -- A person battling multiple sclerosis spent an average of $750 in ...